Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Two Markman Victories..does .14 cents per share seem even remotely appropriate?

I agree! The scar tissue of the past 5 years and the failed expectations of certain events is keeping the PPS artificially low. I think when we get a communication from TPL explaining the situation and or series of licenses that shed some of the ongoing doubt about the strength of the patent our PPS will trade on different values like how big the dividend will be the next quarter based on signings. It will be happier times for all longs.

GL

Share
New Message
Please login to post a reply